Antipsychotic meds decisions in assisted living require system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic drugs require balancing regulatory goals with resident-centered practices, researchers say.
Vigorous exercise may guard against death from Alzheimer’s disease
By
Kristen Fischer
Dec 18, 2023
Engaging in vigorous activity compared to moderate exercise may lower the rate of dying from Alzheimer’s disease, according to a new study. The study was published in the December issue of The Lancet...
Two new studies identify potential warning signs of cognitive decline in older adults
By
John Roszkowski
Oct 13, 2023
Older adults who show subtle decline on standard memory and cognitive tests may be at increased risk for developing mild cognitive impairment, a precursor to dementia, according to the results of a new...
Who uses the care planning code? Memory-care expert says the answer matters
By
Alicia Lasek
Nov 21, 2019
A memory-care expert is the latest advocate for greater use and expansion of Medicare’s largely untapped dementia care planning benefit.
FDA advisers to vote on first drug to treat Alzheimer’s
By
Alicia Lasek
Oct 28, 2020
Advisers will consider whether to recommend that the amyloid beta-removing drug aducanumab be approved. The FDA has not reviewed an application for a new Alzheimer’s treatment for at least 15 years.
Can grapes halve a person’s dementia risk?
By
John O'Connor
Jun 22, 2020
People who eat a handful of grapes twice a day might cut their Alzheimer’s disease risk virtually in half, a new study suggests.
43 recommendations help fill gap in medical and mental healthcare guidance for assisted living, experts...
By
Lois A. Bowers
Oct 04, 2022
Forty-three recommendations from a new study will guide medical and mental healthcare and increase care consistency in assisted living, the authors say.
Docs struggle with making MCI diagnoses, 2022 Alzheimer’s report finds
By
Alicia Lasek
Mar 23, 2022
Less than half of primary care physicians surveyed report being comfortable diagnosing mild cognitive impairment that’s due to Alzheimer’s disease. Fully 90% told researchers that it is “hard...
Epilepsy raises risk of developing Alzheimer’s, and vice-versa
By
Alicia Lasek
May 29, 2023
People with a common type of epilepsy have nearly four times the relative odds of receiving an Alzheimer’s diagnosis, a new study finds.
Blood pressure control, not drug type, key to lowering dementia risk
By
Alicia Lasek
Nov 18, 2019
Dementia risk is lower when hypertension is well controlled, no matter the class of blood pressure drug used, according to a recent study.